Status | Study |
Active, not recruiting |
Study Name: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects Condition: Primary Sclerosing Cholangitis Date: 2013-02-21 Interventions: Drug: Oral Vancomycin Other Name: Vancocin |
Completed |
Study Name: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-12-19 Interventions: Drug: norUDCA Comparison of di |
Recruiting |
Study Name: Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-09-10 Interventions: Drug: Mitomycin C Drug: Normal saline |
Completed |
Study Name: Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC) Condition: Sclerosing Cholangitis Date: 2012-03-14 |
Completed |
Study Name: Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-03-11 |
Completed |
Study Name: Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis Condition: Cholangitis, Sclerosing Date: 2011-10-14 Interventions: Drug: Oral all-trans retinoic acid (ATRA) The subjects wil |
Completed |
Study Name: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2010-03-12 Interventions: Drug: ursodeoxycholic acid (UDCA) Pediatric PSC patients already receiving UDCA therapy will enter a fou |
Completed |
Study Name: A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2010-03-10 Interventions: Drug: Vancomycin Comparison of |
Terminated |
Study Name: Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2009-08-04 Interventions: Drug: Thalidomide Titrate to 400 mg daily for 6 months |
Completed |
Study Name: Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatogram (ERCP) Condition: Primary Sclerosing Cholangitis Date: 2009-07-31 |